3SBio Inc (三生制药), the company that Pfizer is working with, was founded by PLA Major General Lou Dan (娄丹).
Lou Dan joined the PLA at the age of 15 at the beginning of the Korean War in 1950. He became a medic and furthered his training after the war.
Lou Dan rose to Major General years later and became Director of the Institute of Microbiology and Immunology at Shenhou Military Medical Research Institute (沈后军事医学研究所).
In 1993, Lou Dan founded Shenyang Sunshine Pharmaceuticals Co Ltd, the government-backed precursor of 3SBio, and served as the chairman and president as well as chief engineer of the company.
Lou Dan’s son Lou Jing (娄竞), current chairman and CEO of 3SBio, obtained a Bachelor of Medicine degree in clinical medicine from Shanghai Second Military Medical University in July 1985. He conducted post-doctoral research at 
NIH after obtaining a PhD in molecular and cell biology from Fordham University in Feb 1994.
reuters.com/business/healt
forbes.com/sites/janeho/2
Quote
Byron Wan
@Byron_Wan
Pfizer would license experimental cancer drug SSGJ-707 from 3SBio Inc (三生制药) — which was founded by PLA Major General Lou Dan (娄丹), paying $1.25 billion upfront and up to another $4.8 billion if developmental milestones are met. Pfizer also plans to make a $100
Show more 3SBio Inc (三生制药) — which was founded by PLA Major General Lou Dan (娄丹), paying $1.25 billion upfront and up to another $4.8 billion if developmental milestones are met. Pfizer also plans to make a $100